CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...
Phase 2, Phase 3
Toronto, Canada and 13 other locations
This is a phase 2 study of investigational drug niraparib and TSR-042 in patients with advanced/recurrent endometrial cancer. The p ...
Phase 2
Toronto, Ontario, Canada and 6 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Hamilton, Ontario, Canada and 318 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Toronto, Ontario, Canada and 253 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Mississauga, Ontario, Canada and 243 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
Toronto, Canada and 100 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Toronto, Ontario, Canada and 201 other locations
This study specifically aims to evaluate how well mocertatug rezetecan (Mo-Rez) works in treating Endometrial Cancer (EC) compared ...
Phase 3
Toronto, Ontario, Canada and 25 other locations
The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth f...
Phase 3
Toronto, Canada and 180 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Toronto, Ontario, Canada and 168 other locations
Clinical trials
Research sites
Resources
Legal